Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GMPs not enough – CSPI

This article was originally published in The Tan Sheet

Executive Summary

The Center for Science in the Public Interest says dietary supplement good manufacturing practices are not enough to ensure supplements are safe and effective because quality control measures are left up to companies. The consumer advocacy group also asserts the regulation will not "address whether the products carry adequate directions for use and appropriate warnings." FDA posted the long-awaited GMPs for advanced display on the Federal Register June 22 (1"The Tan Sheet" June 25, 2007, p. 3). While firms must retain all records of adverse events FDA will only investigate high-risk firms and "given FDA's limited resources that may be as infrequently as once every 5 or 10 years," CSPI says...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100661

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel